Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Lloyds Banking Group stock near £1: CEO pay shake-up hits headlines as buyback bets build

Lloyds Banking Group stock near £1: CEO pay shake-up hits headlines as buyback bets build

Lloyds is preparing a new pay policy that could raise CEO Charlie Nunn’s maximum award to £13.2 million, the Guardian reported. Shareholders will vote on the plan at the annual meeting, as peers have also lifted pay ceilings. Lloyds shares closed at 100.30p Friday, near a 52-week high. Investors await the bank’s Jan. 29 results for updates on dividends, buybacks, and motor finance redress.
Imperial Brands PLC stock: Buyback update lands as shares slip and AGM clock ticks

Imperial Brands PLC stock: Buyback update lands as shares slip and AGM clock ticks

Imperial Brands shares closed down 0.3% at 3,011 pence Friday as the company disclosed a £1.45 billion buyback for cancellation. A regulatory filing showed 194,893 shares were bought Jan. 9 at an average 3,004.20 pence. The FTSE 100 hit a record, but Imperial lagged peers like British American Tobacco, which rose 1.25%. Investors await the Jan. 28 AGM and Feb. 19 ex-dividend date.
Barclays stock: buyback update lands as investors eye CPI and bank earnings week

Barclays stock: buyback update lands as investors eye CPI and bank earnings week

Barclays repurchased 2.07 million shares for cancellation on Jan. 8 as part of its ongoing buyback, with shares closing Friday up 0.04% at 484.9 pence. Trading volume reached 16.5 million shares. Attention turns to U.S. CPI data and major U.S. bank earnings on Jan. 13, which could impact rate expectations and bank stocks. Barclays will release full-year results on Feb. 10.
Palantir (PLTR) faces fresh valuation test as investor says “too early to call” despite Truist’s $223 target

Palantir (PLTR) faces fresh valuation test as investor says “too early to call” despite Truist’s $223 target

Palantir shares have dropped 14% since November’s Q3 report, with Wall Street holding a consensus Hold rating and a $190 average price target. Truist began coverage this week with a Buy rating and a $223 target, citing 63% annual growth and strong margins. Shares rose 0.3% to $177.49. Accenture announced plans to acquire U.K. AI firm Faculty, a Palantir competitor.
11 January 2026
Unilever PLC stock rises into the weekend as investors eye U.S. CPI and Feb results

Unilever PLC stock rises into the weekend as investors eye U.S. CPI and Feb results

Unilever shares closed up 1.7% at 4,744 pence Friday, lifted by a broader rally after the U.S. jobs report. The FTSE 100 hit a record high, with traders watching U.S. inflation data due Jan. 13 and Unilever’s full-year results on Feb. 12. The company recently spun off its ice cream business and completed an 8-for-9 share consolidation. Investors remain cautious on growth and margin outlooks.
11 January 2026
Vodafone stock slips into weekend as buybacks roll on and India stake resurfaces

Vodafone stock slips into weekend as buybacks roll on and India stake resurfaces

Vodafone shares fell 2.36% Friday to 101.20 pence, closing below the company’s recent buyback price. Vodafone bought 1.36 million shares at an average 103.38 pence on Jan. 8. India’s government capped Vodafone Idea’s annual dues at $13.79 million for six years, but the unit continues to post losses. The interim dividend is set for payment on Feb. 5, with a trading update due the same day.
11 January 2026
1 208 209 210 211 212 535

Stock Market Today

AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026
AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.
Toyota stock price rises on CEO shake-up and higher profit outlook as buyout deadline nears

Toyota stock price rises on CEO shake-up and higher profit outlook as buyout deadline nears

7 February 2026
Toyota shares rose 2% to 3,780 yen Friday after the company raised its full-year profit forecast and announced CFO Kenta Kon will replace CEO Koji Sato on April 1. Third-quarter net revenues climbed 6.8% to 38.087 trillion yen, but North America posted a 5.6 billion yen operating loss. Toyota’s U.S. ADRs closed up 2.9%. The tender offer for Toyota Industries shares closes Feb. 12.
Go toTop